30.08.2023 Zur Profilseite

EQS-News: SUSE S.A.: SUSE Q3 FY23 Quarterly Statement

EQS-News: SUSE S.A. / Key word(s): Quarter Results
SUSE S.A.: SUSE Q3 FY23 Quarterly Statement

30.08.2023 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.

SUSE Q3 FY23 Quarterly Statement

Q3 IFRS Revenue of $173 million was up 2% versus the prior year, and IFRS Operating Profit Before D&A was $36 million, down 11%, reflecting continued investments in initiatives to support future growth
ARR (as at April 30, 2023) of $665 million was up 4%
Adjusted Revenue of $173 million, up 1% (same at constant currency), was supported by earlier-than-expected revenue from retrospective consumption contracts
Adjusted EBITDA Margin of 32%, down 6 ppt, also reflects investments into initiatives to support future growth, including in R&D
Adjusted Unlevered Free Cash Flow of $60 million, down 2%, with cash conversion of 108%, was supported by a core working capital inflow
During Q3 FY23 and since the end of the quarter, SUSE’s expectations for future performance and market outlooks have not changed materially
There will be no further announcement of Q3 results, previously due on September 21, 2023, and no management conference call today

On August 17, 2023, post quarter end, SUSE announced that its majority shareholder Marcel LUX III SARL (EQT Private Equity) intends to take the company private by delisting it from the Frankfurt Stock Exchange. As part of that, EQT Private Equity announced a voluntary public purchase price offer to acquire the shares it does not own. The offer price per SUSE share to be paid by EQT Private Equity will be EUR 16.00 less the gross amount per SUSE share of an interim dividend to be paid by SUSE to all shareholders, representing a premium of 67% on the XETRA closing share price on 17 August
The interim dividend will be funded by SUSE through a combination of existing cash and additional borrowing and will be paid to all shareholders, allowing EQT Private Equity to finance its purchase of SUSE shares under the offer and certain transaction costs. For more information see ir.suse.com
SUSE’s Management Board and Supervisory Board support the strategic opportunity from delisting of the company as it will allow SUSE to focus fully on its operational priorities and execution of its long-term strategy
On August 14, 2023, SUSE announced the appointments of Ian Halifax as Chief Financial Officer from December 11, 2023, and Frank Feldman as Chief Strategy Officer with immediate effect. These appointments completed SUSE’s strengthened executive leadership team

All USD $m unless otherwise stated	FY23 Q3	FY22 Q3	YoY Actual	YoY CCY	FY23 Q3 YTD	FY22 Q3 YTD	YoY Actual	YoY CCY
Non-IFRS measures
ACV	117.0	114.4	2%	1%	394.6	397.6	(1)%	0%
ARR (as at April 30)	664.9	639.6	4%		664.9	639.6	4%
Adjusted Revenue	173.3	171.2	1%	1%	504.7	487.5	4%	4%
Adjusted EBITDA	55.9	65.1	(14)%	(12)%	175.2	176.0	(0)%	(3)%
Adjusted EBITDA Margin	32%	38%			35%	36%
Adjusted uFCF	60.1	61.5	(2)%		151.5	143.8	5%
IFRS measures
Revenue	173.0	170.1	2%		503.3	483.4	4%
Gross Profit	159.4	156.8	2%		462.5	444.7	4%
Operating Profit Before D&A	36.2	40.8	(11)%		118.8	107.9	10%
Net Cash Inflow from Operating Activities	40.9	54.0	(24)%		103.4	105.1	(2)%

Luxembourg – August 30, 2023 – SUSE S.A. (the “Company” or “SUSE”), an independent leader in open source software specializing in Enterprise Linux operating systems, Enterprise Container Management and Edge software solutions, today announced its results for the third quarter of financial year 2023, which ended July 31, 2023.

Notes

This document contains Alternative Performance Measures as defined in Appendix 4.

Operating expenses exclude non-recurring items, as shown in the IFRS operating loss to Adjusted EBITDA reconciliation in Appendix 2.

Constant Currency movements (CCY) have been provided for ACV, Adjusted Revenue and Adjusted EBITDA. The definition of constant currency is included within Appendix 4.

Statutory data for the financial period is reported in Appendix 1. Reconciliations to IFRS measures are shown in Appendix 2.

Summary IFRS Income Statement, KPIs and Adjusted Profit and Loss for Q3 and Q3 YTD FY23, and Q3 and Q3 YTD FY22

Summary IFRS Income Statement

All USD $m unless otherwise stated	FY23 Q3	FY22 Q3	YoY Actual	FY23 Q3 YTD	FY22 Q3 YTD	YoY Actual

Revenue	173.0	170.1	2%	503.3	483.4	4%
Cost of sales	(13.6)	(13.3)	2%	(40.9)	(38.7)	6%
Gross profit	159.4	156.8	2%	462.4	444.7	4%
Operating expenses	(123.2)	(116.0)	6%	(343.6)	(336.8)	2%
Amortization of intangible assets	(34.4)	(35.2)	(2)%	(102.7)	(107.6)	(5)%
Depreciation - PPE	(1.2)	(0.9)	33%	(3.3)	(2.8)	18%
Depreciation - Right of Use assets	(1.2)	(1.7)	(29)%	(4.2)	(5.9)	(29)%
Operating profit/(loss)	(0.6)	3.0	n.m.	8.6	(8.4)	n.m.
Net finance costs	(12.5)	(9.1)	37%	(40.1)	(30.7)	31%
Share of losses on associate	(0.2)	(0.3)	(33)%	(1.4)	(1.7)	(18)%
Profit/(Loss) before tax	(13.3)	(6.4)	108%	(32.9)	(40.8)	(19)%
Taxation	(0.7)	(6.5)	(89)%	(6.6)	1.4	n.m.
Profit/(Loss) for the period	(14.0)	(12.9)	9%	(39.5)	(39.4)	0%

KPIs and Adjusted Profit and Loss

All USD $m unless otherwise stated	FY23 Q3	FY22 Q3	YoY Actual	YoY CCY	FY23 Q3 YTD	FY22 Q3 YTD	YoY Actual	YoY CCY
ACV by Solution
Core	93.4	93.2	0%	(1)%	319.4	326.7	(2)%	(1)%
Emerging	23.6	21.2	11%	11%	75.2	70.9	6%	7%
Total ACV	117.0	114.4	2%	1%	394.6	397.6	(1)%	0%

ARR (as at April 30)	664.9	639.6	4%		664.9	639.6	4%
NRR as % (as at April 30)	100.4%	107.6%	(7)%		100.4%	107.6%	(7)%

Adjusted Revenue by Solution
Core	144.0	142.9	1%	0%	413.5	407.0	2%	2%
Emerging	29.3	28.3	4%	4%	91.2	80.5	13%	13%
Total Adjusted Revenue	173.3	171.2	1%	1%	504.7	487.5	4%	4%
Adjusted Cost of Sales	13.4	13.3	1%	0%	40.2	38.2	5%	7%
Adjusted Gross Profit	159.9	157.9	1%	1%	464.5	449.3	3%	3%
Adjusted Gross Profit Margin	92%	92%			92%	92%

Sales, Marketing & Operations	47.7	45.0	6%	5%	134.2	134.3	(0)%	2%
Research & Development	33.4	27.1	23%	21%	93.1	81.2	15%	16%
General & Administrative	22.9	20.7	11%	6%	62.0	57.8	7%	9%
Total Operating Expenses	104.0	92.8	12%	10%	289.3	273.3	6%	8%

Adjusted EBITDA	55.9	65.1	(14)%	(12)%	175.2	176.0	(0)%	(3)%
Adjusted EBITDA Margin	32%	38%			35%	36%
Depreciation & Amortization	4.9	5.0	(2)%		15.0	16.3	(8)%
Adjusted EBIT	51.0	60.1	(15)%		160.2	159.7	0%
Net Finance Costs	12.5	9.1	37%		40.1	30.7	31%
Adjusted Profit Before Tax	38.5	51.0	(25)%		120.1	129.0	(7)%
Notional Tax	11.0	14.2	(23)%		38.4	37.2	3%
Adjusted Profit After Tax	27.5	36.8	(25)%		81.7	91.8	(11)%
Weighted average shares in issue	170.6	169.2	1%		169.9	169.1	0%
Basic Adjusted Earnings Per Share	0.16	0.22	(27)%		0.48	0.54	(11)%
Diluted Adjusted Earnings Per Share	0.16	0.21	(24)%		0.47	0.53	(11)%

Notes: Basic Adjusted Earnings Per Share is calculated on the basis of the weighted average number of ordinary shares in issue during the period. Diluted Adjusted Earnings Per Share takes into account potential dilution from outstanding share grants and options. The weighted average number of ordinary shares in issue, fully diluted, during the third quarter, was 174.2 million, and during the Q3 YTD FY23 was 173.5 million.

Financial and Business Review

The information in this section is based on the presentation of Alternative Performance Measures as defined in Appendix 4 and has not been audited.

A reconciliation to the IFRS financials is included in Appendix 2. Results are shown using actual exchange rates.

Business and Markets Update

On August 17, 2023, post quarter end, SUSE announced that its majority shareholder Marcel LUX III SARL (EQT Private Equity) intends to take the company private by delisting it from the Frankfurt Stock Exchange via a merger into an unlisted Luxembourg entity in the legal form of an S.A. As part of that, EQT Private Equity has announced a voluntary public purchase price offer to acquire the shares it does not own. The offer price per SUSE share to be paid by EQT Private Equity will be EUR 16.00 less the gross amount per SUSE share of an interim dividend to be paid by SUSE to all shareholders, representing a premium of 67% on the XETRA closing share price on 17 August.

The interim dividend will be paid to all shareholders prior to the settlement of the offer and will allow EQT Private Equity to finance its purchase of SUSE shares under the offer and certain transaction costs incurred by it. The payment of the interim dividend will be funded by SUSE through a combination of existing cash and additional borrowing. Any additional borrowing will be in the form of loans taken out by companies of the SUSE group to a maximum of EUR 500 million. The amount of the loans taken out will only be determined after the expiry of the offer acceptance period.

SUSE’s Management Board and Supervisory Board support the strategic opportunity from delisting of the company as it will allow SUSE to focus fully on its operational priorities and execution of its long-term strategy.

For more information, see the press release and ad hoc announcement at https://ir.suse.com/websites/suse/English/4900/eqt-purchase-offer.html

On August 14, 2023, SUSE announced the appointments of Ian Halifax as Chief Financial Officer from December 11, 2023, and Frank Feldman as Chief Strategy Officer with immediate effect. These appointments completed SUSE’s strengthened executive leadership team.

Ian Halifax will take over as CFO on December 11, 2023, following a handover with the interim CFO Jonathan Atack, who retains full responsibility for the role until then. Ian Halifax has more than 30 years' experience in senior financial leadership positions, including as Chief Financial Officer at leading global technology providers such as Trellix, Riverbed Technology, ON24, Wind River Systems and Micromuse. He has substantial strategic and executional experience in private and public technology companies, and he has developed and led global teams to drive performance, rapid growth and diversification.

Frank Feldmann’s career includes more than 15 years in several senior management roles at Red Hat, as well as at Novell. Feldmann has a strong foundation in technology product management, sales and technology marketing, focused on business and technology transformation and growth. His role at SUSE includes the development and execution of long-term business strategies.

ACV and Revenues

Q3 ACV was $117.0 million, up 2%, comprising Core ACV of $93.4 million, flat versus the prior year, and Emerging ACV of $23.6 million, up 11%. At constant currency, Q3 total ACV growth was up 1%, Core was down 1% and Emerging up 11%.

Q3 Adjusted Revenue was $173.3 million, up 1%, comprising Core Revenue of $144.0 million, up 1%, and Emerging Revenue of $29.3 million, up 4%. At constant currency, movements are the same for total Adjusted Revenue and Emerging Revenue, with Core Revenue flat versus the prior year.

The average contract duration on a last-12-months basis was 18 months, the same as the prior quarter. This only considers contracts paid up front.

ACV – By Route-to-Market

All USD $m unless otherwise stated	FY23 Q3	FY22 Q3	YoY Actual	FY23 Q3 YTD	FY22 Q3 YTD	YoY Actual

End User & Cloud	108.0	101.9	6%	343.8	335.9	2%
IHV & Embedded	9.0	12.5	(28)%	50.8	61.7	(18)%
Total ACV	117.0	114.4	2%	394.6	397.6	(1)%

End User and Cloud ACV was up 6% in Q3, driven by growth in both Cloud and End User routes-to-market.

Independent Hardware Vendors (IHV) and Embedded ACV declined 28% in Q3, driven by lower hardware shipments and a shift to selling through other routes, primarily through Cloud Service Providers.

ACV – By Region

All USD $m unless otherwise stated	FY23 Q3	FY22 Q3	YoY Actual	FY23 Q3 YTD	FY22 Q3 YTD	YoY Actual

Europe, Middle East and Africa	53.8	41.4	30%	178.8	159.7	12%
North America	43.8	53.6	(18)%	154.0	171.5	(10)%
Asia Pacific and Japan	9.7	10.8	(10)%	29.1	28.5	2%
Greater China	5.4	4.6	17%	16.9	20.8	(19)%
Latin America	4.3	4.0	8%	15.8	17.1	(8)%
Total ACV	117.0	114.4	2%	394.6	397.6	(1)%

Annual Recurring Revenue and Net Retention Rate

Total Annual Recurring Revenue (ARR) as at April 30, 2023, was $664.9 million, up 4%.

SUSE’s Net Retention Rate (NRR) as at April 30, 2023, was 100.4%.

ARR and NRR are reported three months in arrears as a significant portion of the revenues are invoiced retrospectively.

Costs

SUSE’s Q3 Adjusted Cost of Sales grew broadly in line with Adjusted Revenue versus the prior year, resulting in a consistently high Adjusted Gross Profit margin of 92%.

Total Operating Expenses increased by 12% in Q3, 10% at constant currency.

Profitability

All USD $m unless otherwise stated	FY23 Q3	FY22 Q3	YoY Actual	FY23 Q3 YTD	FY22 Q3 YTD	YoY Actual

Adjusted EBITDA	55.9	65.1	(14)%	175.2	176.0	(0)%
Adjusted EBITDA Margin	32%	38%		35%	36%
Change in Deferred Revenue	(13.6)	(18.9)	(28)%	(17.8)	39.2	n.m
Adjusted Cash EBITDA	42.3	46.2	(8)%	157.4	215.2	(27)%
Adjusted Cash EBITDA Margin	24%	27%		31%	44%

Adjusted EBITDA declined 14% versus the prior year, as revenue growth was more than offset by higher operating costs.

Change in Deferred Revenue was negative $13.6 million, despite higher ACV and stable contract lengths in Q3 versus the prior year, as revenue recognition more than offset the total contract value booked in the period.

The decrease in Adjusted EBITDA was partly offset by the lower negative Change in Deferred Revenue, leading to Q3 Adjusted Cash EBITDA of $42.3 million, down 8%.

Cash Flow

All USD $m unless otherwise stated	FY23 Q3	FY22 Q3	YoY Actual	FY23 Q3 YTD	FY22 Q3 YTD	YoY Actual

Adjusted Cash EBITDA	42.3	46.2	(8)%	157.4	215.2	(27)%

Gross capital expenditure	(1.3)	(2.5)	(48)%	(6.9)	(7.2)	(4)%
Change in core working capital	27.5	27.2	1%	30.6	(27.2)	n.m.
Commission paid (net of amortization)	(2.6)	(5.3)	(51)%	(10.9)	(18.6)	(41)%
Leases paid	(2.1)	(1.9)	11%	(6.3)	(5.7)	11%
Cash taxes	(3.7)	(2.2)	68%	(12.4)	(12.7)	(2)%
Adjusted uFCF	60.1	61.5	(2)%	151.5	143.8	5%
Adj. uFCF Conv from Adj. EBITDA	108%	94%		86%	82%

Adjusted Unlevered Free Cash Flow of $60.1 million in Q3 was down 2% versus the prior year, driven primarily by the lower Adjusted Cash EBITDA, partly offset by lower commissions paid (net of amortization). The Core Working Capital inflow of $27.5 million in Q3 was broadly similar to the prior year, reflecting customer payment for contracts signed in the prior quarter.

Leverage

All USD $m unless otherwise stated	FY23 End Q3	FY22 End Q3	YoY Actual

Net Debt	507.3	604.1	(16)%
Adjusted Cash EBITDA (LTM)	237.4	266.9	(11)%
Leverage	2.1	2.3	(9)%

Net Debt at the end of Q3 was $507.3 million, a reduction of $96.8 million versus the prior year, driven by SUSE’s strong cash flow.

Outlook

During Q3 FY23 and since the end of the quarter, SUSE’s expectations for future performance and market outlooks have not changed materially.

Additional Information

About SUSE

SUSE is a global leader in innovative, reliable and secure enterprise-grade open source solutions, relied upon by more than 60% of the Fortune 500 to power their mission-critical workloads. The company behind Rancher, NeuVector and SUSE Linux Enterprise (SLE), SUSE collaborates with partners and communities to empower customers to innovate everywhere – from the data center to the cloud, to the edge and beyond. SUSE puts the “open” back in open source, giving customers the ability to tackle innovation challenges today and the freedom to evolve their strategy and solutions tomorrow. The company employs more than 2,400 people globally and is listed on the Frankfurt Stock Exchange. For more information, visit www.suse.com.

For reference you'll find all releases here https://www.suse.com/news/

Contacts

Investors:

Matt Jones

Investor Relations, SUSE

Phone: +44 7809 690 336

Email: [email protected]

Media:

Christopher Deifuss

Kekst CNC

Phone: +49 162 2059754

Email: [email protected]

Monique Perks

Kekst CNC

Phone: +44 758 1033 557

Email: [email protected]

Webcast Details

There will be no management conference call covering Q3 FY23 results. Please see above contact details for any questions.

Important Notice

Certain statements in this communication may constitute forward-looking statements. These statements are based on assumptions that are believed to be reasonable at the time they are made, and are subject to significant risks and uncertainties, including, but not limited to, those risks and uncertainties described in SUSE's disclosures. You should not rely on these forward-looking statements as predictions of future events, and we undertake no obligation to update or revise these statements. Our actual results may differ materially and adversely from any forward-looking statements discussed in these statements due to several factors, including without limitation, risks from macroeconomic developments, external fraud, lack of innovation capabilities, inadequate data security and changes in competition levels.

The Company undertakes no obligation, and does not expect to publicly update, or publicly revise, any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable to it or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements referred to above and contained elsewhere in this communication.

APPENDIX 1 IFRS Figures

Interim Condensed Consolidated Statement of Comprehensive Income (unaudited)

For the nine months ended 31 July 2023

	Nine months ended 31 July 2023			Nine months ended 31 July 2022
		Separately			Separately
Income statement:	Headline	reported items	Total	Headline	reported items	Total
	US$’000	US$’000	US$’000	US$’000	US$’000	US$’000
Revenue	503,307	-	503,307	483,409	-	483,409
Cost of sales	(40,857)	-	(40,857)	(38,751)	-	(38,751)
Gross profit	462,450	-	462,450	444,658	-	444,658
Selling and distribution costs	(140,646)	(6,836)	(147,482)	(136,914)	-	(136,914)
Research and development costs	(95,858)	-	(95,858)	(86,075)	-	(86,075)
Administrative expenses	(100,940)	-	(100,940)	(114,378)	-	(114,378)
Impairment credit on trade receivables	657	-	657	531	-	531
Operating profit before depreciation/impairment and amortization	125,663	(6,836)	118,827	107,822	-	107,822

Amortization of intangible assets	(102,707)	-	(102,707)	(107,568)	-	(107,568)
Depreciation – Property, plant and equipment	(3,266)	-	(3,266)	(2,760)	-	(2,760)
Depreciation/impairment – Right of use assets	(4,237)	-	(4,237)	(5,888)	-	(5,888)
Operating profit/( loss)	15,453	(6,836)	8,617	(8,394)	-	(8,394)

Finance costs	(44,132)	-	(44,132)	(30,949)	-	(30,949)
Finance income	4,074	-	4,074	268	-	268
Net finance costs	(40,058)	-	(40,058)	(30,681)	-	(30,681)

Share of losses of associate	(1,501)	-	(1,501)	(1,745)	-	(1,745)
Loss before tax	(26,106)	(6,836)	(32,942)	(40,820)	-	(40,820)

Taxation	(8,295)	1,706	(6,589)	1,419	-	1,419
Loss for the period	(34,401)	(5,130)	(39,531)	(39,401)	-	(39,401)
Attributable to:
Equity shareholders of the parent	(34,401)	(5,130)	(39,531)	(39,401)	-	(39,401)
Non-controlling interests	-	-	-	-	-	-
Loss for the period	(34,401)	(5,130)	(39,531)	(39,401)	-	(39,401)

Basic loss per share (USD/share) ⁽¹⁾			(0.2)			(0.2)

⁽¹⁾For the nine months ended 31 July 2023 and 31 July 2022, potential ordinary shares are anti-dilutive, as their inclusion in the diluted loss per share calculation would reduce the loss per share, and hence have been excluded.

Interim Condensed Consolidated Statement of Comprehensive Income (unaudited)

For the nine months ended 31 July 2023

	Nine months ended 31 July 2023			Nine months ended 31 July 2022
		Separately			Separately
	Headline	reported items	Total	Headline	reported items	Total
	US$’000	US$’000	US$’000	US$’000	US$’000	US$’000

Loss for the period	(34,401)	(5,130)	(39,531)	(39,401)	-	(39,401)

Other comprehensive (loss)/income:

Items not to be reclassified to income statement:
Remeasurement of defined benefit pension schemes	325	-	325	2,304	-	2,304
Related tax impact	(8)	-	(8)	(706)	-	(706)

Items that may be reclassified to income statement:
Currency translation differences	(32,587)	-	(32,587)	48,671	-	48,671
Cash flow hedge – changes in fair value	7,832	-	7,832	(49)	-	(49)
Cash flow hedge – reclassified to income statement	89	-	89	4,386	-	4,386
Related tax impact	(1,861)	-	(1,861)	(1,003)	-	(1,003)
Other comprehensive (loss)/income for the period	(26,210)	-	(26,210)	53,603	-	53,603

Total comprehensive (loss)/income for the period	(60,611)	(5,130)	(65,741)	14,202	-	14,202

Attributable to:
Equity shareholders of the parent	(60,611)	(5,130)	(65,741)	14,202	-	14,202
Non-controlling interests	-	-	-	-	-	-
Total comprehensive (loss)/income for the period	(60,611)	(5,130)	(65,741)	14,202	-	14,202

Interim Condensed Consolidated Statement of Financial Position (unaudited)

As at 31 July 2023

As at
31 July 2023

As at
31 October 2022

US$’000

Non-current assets

Goodwill

2,686,320

Intangible assets

294,269

393,427

Property, plant and equipment

17,580

13,914

Right of use assets

16,681

18,089

Investment in associate

10,775

12,276

Derivative asset

12,194

4,051

Long-term pension assets

569

484

Other receivables

8,813

8,697

Deferred tax assets

184,374

178,680

Contract related assets

94,714

78,183

3,326,289

3,394,121

Current assets

Trade and other receivables

111,943

158,044

Current tax receivables

3,597

Cash and cash equivalents

258,787

177,544

Contract related assets

32,307

37,796

406,634

376,981

Total assets

3,732,923

3,771,102

Current liabilities

Trade and other payables

88,633

110,490

Borrowings

3,600

Lease liabilities

6,705

6,249

Provisions

692

337

Current tax liabilities

7,950

10,113

Deferred income – contract liabilities

361,186

351,197

468,766

481,986

Non-current liabilities

Borrowings

730,675

695,989

Lease liabilities

12,458

14,431

Provisions

1,043

1,033

Non-current tax liabilities

8,083

Deferred tax liabilities

102,050

98,831

Retirement benefit obligations

2,163

2,142

Deferred income – contract liabilities

188,700

215,034

Other payables

2,574

3,861

1,047,746

1,039,404

Total liabilities

1,516,512

1

Die wichtigsten Finanzdaten auf einen Blick

2017 2018 2019 2020 2021 2022 2023

Umsatzerlöse¹ 0,00 0,00 0,00 0,00 0,00 0,00 0,00

EBITDA^1,2 0,00 0,00 0,00 0,00 0,00 0,00 0,00

EBITDA-Marge³ 0,00 0,00 0,00 0,00 0,00 0,00

EBIT^1,4 0,00 0,00 0,00 0,00 0,00 0,00 0,00

EBIT-Marge⁵ 0,00 0,00 0,00 0,00 0,00 0,00 0,00

Jahresüberschuss¹ 0,00 0,00 0,00 0,00 0,00 0,00 0,00

Netto-Marge⁶ 0,00 0,00 0,00 0,00 0,00 0,00 0,00

Cashflow^1,7 0,00 0,00 0,00 0,00 0,00 0,00 0,00

Ergebnis je Aktie⁸ 0,00 0,00 0,00 0,00 0,00 0,00 0,00

Dividende⁸ 0,00 0,00 0,00 0,00 0,00 0,00 0,00

Quelle: boersengefluester.de und Firmenangaben

¹ in Mio. Euro; ² EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; ³ EBITDA in Relation zum Umsatz; ⁴ EBIT = Ergebnis vor Zinsen und Steuern; ⁵ EBIT in Relation zum Umsatz; ⁶ Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; ⁷ Cashflow aus der gewöhnlichen Geschäftstätigkeit; ⁸ in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer:

INVESTOR-INFORMATIONEN

©boersengefluester.de

WKN Kurs in € Einschätzung Börsenwert in Mio. €

0,000 0,00

KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV

0,00 0,00 0,00 0,00

KBV KCV KUV EV/EBITDA

0,00 0,00 0,00 0,00

Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in % Hauptversammlung

0,00 0,00 0,00
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK

Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen

0,00% 0,00% 0,00% 0,00%